Labcorp Holdings Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 0JSY.L | 4544.T | 4694.T | TRIB | BMRA | QDEL | |
|---|---|---|---|---|---|---|
| Market cap | — | 199.33B | 143.37B | 6.40M | 8.26M | 895.25M |
| P/E (TTM) | 14.8 | 21.6 | 18.3 | — | — | — |
| Forward P/E | — | 36.1 | 25.7 | -7.6 | 4.6 | 9.1 |
| Price/book | 3.0 | 1.5 | 1.1 | -0.1 | 2.3 | 0.5 |
| Dividend yield | 0.90% | 3.36% | 3.26% | — | — | — |
| 1-year change | −1.53% | −5.83% | +5.94% | −74.01% | −40.71% | −55.48% |
| Today | +0.79% | −0.78% | −0.26% | −1.99% | −2.97% | +1.12% |
The closest companies by business. Prices may be delayed up to 20 min.
Latest news
All 0JSY.L news ›Clinical Research Jobs at Labcorp | Apply Now
A rare chance has emerged for aspiring Clinical Data Analysts to join Labcorp in Bengaluru, India. This full-time position offers an opportunity to contribute to improving health and lives through innovative laboratory services. Interested…
Labcorp Holdings Inc. $LH Shares Sold by Birch Hill Investment Advisors LLC
Posted by Defense World Staff on Oct 18th, 2026 View Our Latest Stock Report on Labcorp Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Labcorp Holdings Inc.…
Burlington’s Labcorp to Acquire Select BioReference Health Assets From OPKO Health for $722 Million
Labcorp expects the acquired business to generate approximately $250 million in revenue in the first year after closing, based on its current forecasts. The transaction is subject to regulatory approvals and customary closing conditions.…
Labcorp to buy select assets of OPKO’s BioReference Health for up to $872M
Seeking Alpha Labcorp (LH) has inked a deal worth up to $872M to acquire a portfolio of assets held by BioReference Health LLC, a subsidiary of OPKO Health (OPK), the companies announced on Thursday. OPKO (OPK) shares added more than 20% in
Labcorp to Acquire Select BioReference Health Assets for $722M
Oct 15, 2026 | Company News | Labcorp has entered into an agreement with OPKO Health to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO, for $722 million. In addition to laboratory facilities and patient…
Labcorp to buy select assets from Opko Health unit for up to $872 million
Laboratory operator Labcorp said on Thursday it will buy some assets from Opko Health's subsidiary in a $722 million cash deal, with a potential additional payment of up to $150 million tied to... Healthcare Facilities & Services Labcorp…
Labcorp to buy more Opko Health assets in $722 million deal
The Business Journals Preview this article 1 min The deal includes more than 80 patient service centers and a prostate cancer blood test. Labcorp bought Opko's oncology labs last year for $225 million. Pharma giant AstraZeneca invests $2B…
Labcorp outlays up to $872m to acquire BioReference’s laboratory assets
Labcorp said the agreement will help to improve access to its own laboratory services. Labcorp is outlaying up to $872m to acquire certain laboratory assets from OPKO Health subsidiary BioReference Health, including its commercial 4Kscore…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com15
-
tradingview.com4
-
seekingalpha.com3
-
stocktitan.net3
-
gurufocus.com2
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 70 articles, not a forecast.